UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 198

Sortiert nach

Stabilization of the Trigonal High-Temperature Phase of Formamidinium Lead Iodide

The journal of physical chemistry letters, 2015-04, Vol.6 (7), p.1249-1253

2015

Volltextzugriff (PDF)

Synchronized Offset Stacking: A Concept for Growing Large-Domain and Highly Crystalline 2D Covalent Organic Frameworks

Journal of the American Chemical Society, 2016-12, Vol.138 (51), p.16703-16710

2016

Volltextzugriff (PDF)

Efficient Planar Heterojunction Perovskite Solar Cells Based on Formamidinium Lead Bromide

The journal of physical chemistry letters, 2014-08, Vol.5 (16), p.2791-2795

2014

Volltextzugriff (PDF)

Solution Deposition-Conversion for Planar Heterojunction Mixed Halide Perovskite Solar Cells

Advanced energy materials, 2014-10, Vol.4 (14), p.np-n/a

2014

Volltextzugriff (PDF)

A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study

Annals of oncology, 2019-08, Vol.30 (8), p.1279-1288

2019

Volltextzugriff (PDF)

Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response

Annals of oncology, 2022-11, Vol.33 (11), p.1149-1158

2022

Volltextzugriff (PDF)

Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study)

Annals of oncology, 2021-01, Vol.32 (1), p.49-57

2021

Volltextzugriff (PDF)

Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo

Annals of oncology, 2020-09, Vol.31 (9), p.1216-1222

2020

Volltextzugriff (PDF)

Effect of Alendronic Acid on Fracture Healing: A Multicenter Randomized Placebo‐Controlled Trial

Journal of bone and mineral research, 2019-06, Vol.34 (6), p.1025-1032

2019

Volltextzugriff (PDF)

Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer: a subanalysis of data from the randomized phase III GeparSepto trial

Annals of oncology, 2017-03, Vol.28 (3), p.497-504

2017

Volltextzugriff (PDF)

Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44)

Annals of oncology, 2013-12, Vol.24 (12), p.2978-2984

2013

Volltextzugriff (PDF)

Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40—GeparQuattro)

Annals of oncology, 2014-01, Vol.25 (1), p.81-89

2014

Volltextzugriff (PDF)

Oligothiophene-Bridged Conjugated Covalent Organic Frameworks

Journal of the American Chemical Society, 2017-06, Vol.139 (24), p.8194-8199

2017

Volltextzugriff (PDF)

Congruence and trajectories of device-measured and self-reported physical activity during therapy for early breast cancer

Breast cancer research and treatment, 2021-07, Vol.188 (2), p.351-359

2021

Volltextzugriff (PDF)

Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer

Annals of oncology, 2012-09, Vol.23 (9), p.2306-2313

2012

Volltextzugriff (PDF)

Quantitative Computed Tomography (QCT) of the Distal Forearm in Men Using a Spiral Whole-Body CT Scanner – Description of a Method and Reliability Assessment of the QCT Pro Software

Journal of clinical densitometry, 2020-07, Vol.23 (3), p.418-425

2020

Volltextzugriff (PDF)

Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer – The Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29)

European journal of cancer (1990), 2016-09, Vol.64, p.12-21

2016

Volltextzugriff (PDF)

Preparation of Single-Phase Films of CH3NH3Pb(I1–x Br x )3 with Sharp Optical Band Edges

The journal of physical chemistry letters, 2014-08, Vol.5 (15), p.2501-2505

2014

Volltextzugriff (PDF)

Factors predicting relapse in early breast cancer patients with a pathological complete response after neoadjuvant therapy: Pooled analysis based on the GBG database

Annals of oncology, 2019-05, Vol.30, p.iii34-iii34

2019

Volltextzugriff (PDF)

Influence of the orientation of methylammonium lead iodide perovskite crystals on solar cell performance

APL materials, 2014-08, Vol.2 (8), p.081508-081508-6

2014

Volltextzugriff (PDF)

Biceps sheath fluid on shoulder ultrasound as a predictor of rotator cuff tear: analysis of a consecutive cohort

Journal of shoulder and elbow surgery, 2016-10, Vol.25 (10), p.1661-1667

2016

Volltextzugriff (PDF)

Impact of nab-paclitaxel dose reduction on survival of the randomized phase III GeparSepto trial comparing neoadjuvant chemotherapy of weekly nab-paclitaxel (nP) with solvent-based paclitaxel (P) followed by anthracycline/cyclophosphamide for patients with early breast cancer (BC)

Annals of oncology, 2018-10, Vol.29, p.viii60-viii60

2018

Volltextzugriff (PDF)

Germline mutation status and therapy response in patients with triple-negative breast cancer (TNBC): Results of the GeparOcto study

Annals of oncology, 2018-10, Vol.29, p.viii77-viii77

2018

Volltextzugriff (PDF)

Integrating bevacizumab, everolimus, and lapatinib into current neoadjuvant chemotherapy regimen for primary breast cancer. Safety results of the GeparQuinto trial

Annals of oncology, 2011-02, Vol.22 (2), p.301-306

2011

Volltextzugriff (PDF)

1 – 25 von 198

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(169)
Mit Volltextzugriff
(187)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(76)
Life Sciences & Biomedicine
(63)
Humans
(54)
Female
(33)
Biological And Medical Sciences
(31)
Middle Aged
(29)
Medical Sciences
(27)
Adult
(23)
Aged
(23)
Oncology
(23)
Male
(19)
Treatment Outcome
(16)
Tumors
(15)
Animals
(14)
Breast Neoplasms - Drug Therapy
(14)
Physical Sciences
(14)
Surgery
(13)
Chemistry
(11)
Fundamental And Applied Biological Sciences. Psychology
(11)
Social Sciences
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Stabilization of the Trigonal High-Temperature Phase of Formamidinium Lead Iodide

Synchronized Offset Stacking: A Concept for Growing Large-Domain and Highly Crystalline 2D Covalent Organic Frameworks

Efficient Planar Heterojunction Perovskite Solar Cells Based on Formamidinium Lead Bromide

Solution Deposition-Conversion for Planar Heterojunction Mixed Halide Perovskite Solar Cells

A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study

Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response

Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study)

Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo

Effect of Alendronic Acid on Fracture Healing: A Multicenter Randomized Placebo‐Controlled Trial

Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer: a subanalysis of data from the randomized phase III GeparSepto trial

Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44)

Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40—GeparQuattro)

Oligothiophene-Bridged Conjugated Covalent Organic Frameworks

Congruence and trajectories of device-measured and self-reported physical activity during therapy for early breast cancer

Corrigendum to “A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study”: [Annals of Oncology (2019), volume 30:1279-1288]

Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer

Quantitative Computed Tomography (QCT) of the Distal Forearm in Men Using a Spiral Whole-Body CT Scanner – Description of a Method and Reliability Assessment of the QCT Pro Software

Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer – The Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29)

Preparation of Single-Phase Films of CH3NH3Pb(I1–x Br x )3 with Sharp Optical Band Edges

Factors predicting relapse in early breast cancer patients with a pathological complete response after neoadjuvant therapy: Pooled analysis based on the GBG database

Influence of the orientation of methylammonium lead iodide perovskite crystals on solar cell performance

Biceps sheath fluid on shoulder ultrasound as a predictor of rotator cuff tear: analysis of a consecutive cohort

Impact of nab-paclitaxel dose reduction on survival of the randomized phase III GeparSepto trial comparing neoadjuvant chemotherapy of weekly nab-paclitaxel (nP) with solvent-based paclitaxel (P) followed by anthracycline/cyclophosphamide for patients with early breast cancer (BC)

Germline mutation status and therapy response in patients with triple-negative breast cancer (TNBC): Results of the GeparOcto study

Integrating bevacizumab, everolimus, and lapatinib into current neoadjuvant chemotherapy regimen for primary breast cancer. Safety results of the GeparQuinto trial

Suchergebnisse filtern